We found that PON1-RR smokers presented a clinically highly relevant increase of 9.4 points on the Framingham risk index as compared to non-smoking PON1-QQ/QR individuals and thus almost a 10% higher risk for having a myocardial infarction in 10 years. The gene discussed is PON1; the disease is myocardial infarction.